Catalent Pharma Solutions
 |
|
| Public company | |
| Traded as | : CTLT S&P 400 Component |
| Industry | Pharmaceutical Biotechnology |
| Predecessor | Cardinal Health PTS |
| Founded | 2007 |
| Headquarters | Somerset, New Jersey, USA |
|
Number of locations
|
33 |
|
Key people
|
John Chiminski (President, CEO), Matthew Walsh (Executive Vice President, CFO) |
| Services | Drug pre-formulation, formulation, analytical testing, clinical and commercial manufacturing, clinical packaging and supply chain solutions, regulatory consulting |
| Revenue | US$1.83 billion (2014) |
| US $374.4 million (2014) | |
| US $142.4 million (2014) | |
|
Number of employees
|
8,300 (2014) |
| Website | www |
Catalent, Inc. (Catalent Pharma Solutions) is a global provider of drug delivery technology and development solutions for drugs, biologics and consumer health products. Headquartered in Somerset, New Jersey, Catalent operates 33 locations across five continents, producing more than 70 billion doses annually for nearly 7,000 customer products.
Originally created through a series of acquisitions by Cardinal Health Inc., Catalent became independent in 2007. Catalent promotes its ability to increase customers' speed to market and its participation in nearly half of new drug entities approved by the Food and Drug Administration in the last decade. The company currently holds approximately 1,300 patents and patent applications and continues to expand its offerings through investments in emerging technologies. In its fiscal year 2014 (ending June 30), Catalent’s customers included 83 of the top 100 branded drug marketers, 20 of the top 25 generics marketers, 38 of the top 50 biologics marketers, and 19 of the top 20 consumer health marketers globally. On July 31, 2014, Catalent became a public company and is listed on the New York Stock Exchange (NYSE: CTLT).
In 1996, Cardinal Health acquired PCI (Headquarters: Philadelphia, Pennsylvania). PCI (Packaging Coordinators Inc.) is a pharmaceutical contract packing service for commercial and clinical packaging. In 1998, Cardinal Health acquired R.P. Scherer Corporation (Headquarters: Troy, Michigan).Robert Pauli Scherer founded the R.P. Scherer Corporation to commercialize his innovation of softgel encapsulation using the rotary die production process. In 1999, Cardinal Health acquired Automatic Liquid Packaging, Inc. (Headquarters: Woodstock, Ill.), whose Blow-Fill-Seal Technology allowed Cardinal to enter the sterile product market. Cardinal Health also acquired International Processing Corporation (Headquarters: Winchester, Kentucky) for its advanced controlled drug release and coating manufacturing expertise.
In 2002, Cardinal Health acquired Magellan Laboratories Inc., a company that specialized in product development expertise. In 2003, Cardinal Health acquired Gala Biotech (Headquarters: Madison, Wisconsin). Gala Biotech had established technologies surrounding gene insertion and the production of pharmaceutical proteins, which became GPEx® Technology. In the same year, Cardinal Health also acquired Intercare Group PLC, broadening its global capabilities in Europe. In 2004-2006, Cardinal Health further expanded its reach in biotechnology and pharmaceutical markets through multiple other acquisitions.
...
Wikipedia